Tag: Cancer: Prostate
Androgen Deprivation Therapy May Up Risk of Alzheimer Disease
                    ADT exposure linked to subsequent Alzheimer disease diagnosis among elderly men at eight years                
            Urine Biomarker Helps Classify Risk Level in Prostate Cancer
                    Urine-derived extracellular vesicle RNA provides diagnostic, prognostic information in prostate cancer                
            Combination Biopsy Strategy May Identify More Prostate Cancers
                    Lesion-targeted plus systematic sampling appears to maximize the accuracy of first-time prostate biopsy                
            Black Race Not Tied to Worse Prostate Cancer Mortality
                    Findings seen in cohorts of men with nonmetastatic disease after adjusting for nonbiological differences                
            Location of Body Fat Linked to Advanced, Fatal Prostate Cancer
                    Risk for advanced, fatal disease also increased in association with body mass index, waist circumference                
            Fewer Black Men Adopt Active Surveillance for Prostate Cancer
                    Overall, use of active surveillance nearly tripled among both black and nonblack men from 2010 to 2015                
            ASCO: Enzalutamide Beneficial in Metastatic Prostate Cancer
                    Progression-free, overall survival longer for men with metastatic, hormone-sensitive prostate cancer                
            Guidelines Updated for Radiotherapy After Prostatectomy
                    Updates include adjuvant radiotherapy for patients with adverse pathologic findings, hormonal therapies                
            American Urological Association, May 3-6
                    
The American Urological Association 2019 Annual Meeting  The annual meeting of the American Urological Association was held from May 3 to 6 in...                
            AUA: Atenolol Linked to Drop in Low-, Intermediate-Risk Prostate Cancer
                    After adjustment for confounders, atenolol displayed significant protective effect on prostate cancer                
             
                